Oncodesign Precision Medicine Société anonyme

€0.24As of Sun 8 Nov 2026, 12:00 UTC
EPA:ALOPMHealthcare
Country France
PE (Fwd) •••
TSR 4Y CAGR (33.89%)
Div yield —
ROE (89.48%)
Biotechnology
Beta (5Y) (0.56)
PE TTM —
TSR TTM (52.94%)
Mkt cap €4.579M
ROIC (83.44%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
€0.286
18.97%
(73.87%)
Sell 3|0|4|1|4
4Q25
1Q26
2Q26
3Q26
Earnings per share€
—
—
—
—
11.89%
17.90%
4.02%
13.62%
Revenue€M
0.275
0.269
0.270
0.271
8.06%
(0.03%)
(2.16%)
1.15%
Peers (US$5.141M)
Cap (US$)
PE
6.509M
—
5.049M
6.626x
4.895M
—
Capital
TTM
5Y
10Y
Leveragex
0.811
0.721
0.696
EBIT/Intx
4.245
0.819
0.782
Own earn%
(33.69)
41.06
46.92
Sh yield%
33.12
33.55
34.39
Owners
Insiders/Inst%
7.58
43.07
Short interest%
0.80
SBC / revenue%
2.13
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
4
Op margin range%
10–15
$1 testx
0.3
Incr. ROIC%
10